{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:07:01Z","timestamp":1767373621029,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Partnership Against Cancer"},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007582","name":"Alberta Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5095-4","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T20:22:13Z","timestamp":1516825333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta\u2019s Tomorrow Project participants stratified by risk"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3071-4613","authenticated-orcid":false,"given":"Nathan M.","family":"Solbak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Vena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala","family":"Al Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Vaseghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather K.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Elizabeth","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"5095_CR1","unstructured":"Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2017. Toronto: Canadian Cancer Society; 2017. Available at: cancer.ca\/Canadian-Cancer-Statistics-2017-EN.pdf . Accessed 12 July 2017."},{"key":"5095_CR2","doi-asserted-by":"crossref","unstructured":"Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014;47(10-11);921\u201339.","DOI":"10.1016\/j.clinbiochem.2014.04.019"},{"key":"5095_CR3","unstructured":"Canadian Partnership Against Cancer. The Canadian strategy for cancer control: 2017\u20132022 we see progress. Toronto; 2016."},{"key":"5095_CR4","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJM200011303432203","volume":"343","author":"JS Mandel","year":"2000","unstructured":"Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603\u20137.","journal-title":"N Engl J Med"},{"key":"5095_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/00365520410003182","volume":"39","author":"O Kronborg","year":"2004","unstructured":"Kronborg O, J\u00f8rgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39:846\u201351.","journal-title":"Scand J Gastroenterol"},{"key":"5095_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1155\/2012\/486328","volume":"26","author":"L Rabeneck","year":"2012","unstructured":"Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012;26:131\u201347.","journal-title":"Can J Gastroenterol"},{"key":"5095_CR7","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1056\/NEJMoa1114635","volume":"366","author":"RE Schoen","year":"2012","unstructured":"Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345\u201357.","journal-title":"N Engl J Med"},{"key":"5095_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrclinonc.2013.12","volume":"10","author":"EJ Kuipers","year":"2013","unstructured":"Kuipers EJ, R\u00f6sch T, Bretthauer M. Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013;10:130\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"5095_CR9","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2016.5989","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315:2564\u201375.","journal-title":"JAMA"},{"key":"5095_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cgh.2008.12.030","volume":"7","author":"CJ Kahi","year":"2009","unstructured":"Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7:770\u20135. quiz 711","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5095_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1503\/cmaj.090845","volume":"182","author":"JJ Telford","year":"2010","unstructured":"Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA. The cost-effectiveness of screening for colorectal cancer. CMAJ. 2010;182:1307\u201313.","journal-title":"CMAJ"},{"key":"5095_CR12","first-page":"206","volume":"165","author":"Canadian Task Force on Preventive Health Care","year":"2001","unstructured":"Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care. CMAJ. 2001;165:206\u20138.","journal-title":"CMAJ"},{"key":"5095_CR13","unstructured":"Toward Optimized Practice (TOP) Working Group for Colorectal Cancer Screening. Colorectal cancer screening: clinical practice guideline. Edmonton: Toward Optimized Practice; 2008. Available from: http:\/\/www.topalbertadoctors.org ."},{"key":"5095_CR14","unstructured":"Toward Optimized Practice (TOP) Working Group for Colorectal Cancer Screening. Colorectal cancer screening: clinical practice guideline. Edmonton: Toward Optimized Practice; 2013. Available from: http:\/\/www.topalbertadoctors.org ."},{"key":"5095_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1503\/cmaj.151125","volume":"188","author":"CM Bacchus","year":"2016","unstructured":"Canadian Task Force on Preventive Health Care, Bacchus CM, Dunfield L, Gorber SC, Holmes NM, Birtwhistle R, et al. Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188:340\u20138.","journal-title":"CMAJ"},{"key":"5095_CR16","volume-title":"Cancer screening programs population and public heath. Colorectal cancer control: a focus on screening","author":"Alberta Health Services","year":"2013","unstructured":"Alberta Health Services. Cancer screening programs population and public heath. Colorectal cancer control: a focus on screening. 2013."},{"key":"5095_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejca.2005.09.023","volume":"42","author":"AS Butterworth","year":"2006","unstructured":"Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216\u201327.","journal-title":"Eur J Cancer"},{"key":"5095_CR18","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3109\/00365521.2015.1014407","volume":"50","author":"J Burisch","year":"2015","unstructured":"Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942\u201351.","journal-title":"Scand J Gastroenterol"},{"key":"5095_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.gie.2006.06.057","volume":"64","author":"SD Saini","year":"2006","unstructured":"Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc. 2006;64:614\u201326.","journal-title":"Gastrointest Endosc"},{"key":"5095_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1053\/gast.2001.24052","volume":"120","author":"J Askling","year":"2001","unstructured":"Askling J, Dickman PW, Karl\u00e9n P, Brostr\u00f6m O, Lapidus A, L\u00f6fberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356\u201362.","journal-title":"Gastroenterology"},{"key":"5095_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1155\/2005\/359243","volume":"19","author":"SE McGregor","year":"2005","unstructured":"McGregor SE, Bryant HE. Predictors of colorectal cancer screening: a comparison of men and women. Can J Gastroenterol. 2005;19:343\u20139.","journal-title":"Can J Gastroenterol"},{"key":"5095_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ypmed.2014.06.013","volume":"66","author":"CC Murphy","year":"2014","unstructured":"Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med (Baltim). 2014;66:123\u201330.","journal-title":"Prev Med (Baltim)"},{"key":"5095_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0960-9776(03)00100-0","volume":"12","author":"RK Tatla","year":"2003","unstructured":"Tatla RK, Paszat LF, Bondy SJ, Chen Z, Chiarelli AM, Mai V. Socioeconomic status & returning for a second screen in the Ontario breast screening program. Breast. 2003;12:237\u201346.","journal-title":"Breast"},{"key":"5095_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2354.2008.01046.x","volume":"18","author":"ME McDowell","year":"2009","unstructured":"McDowell ME, Occhipinti S, Gardiner RA, Baade PD, Steginga SK. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. Eur J Cancer Care (Engl). 2009;18:545\u201355.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5095_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/ajg.2011.11","volume":"106","author":"ZF Gellad","year":"2011","unstructured":"Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, JR MD, Ostbye T, et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106:1125\u201334.","journal-title":"Am J Gastroenterol"},{"key":"5095_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10900-013-9685-x","volume":"38","author":"DT Liss","year":"2013","unstructured":"Liss DT, Petit-Homme A, Feinglass J, Buchanan DR, Baker DW. Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health. 2013;38:829\u201333.","journal-title":"J Community Health"},{"key":"5095_CR27","first-page":"51","volume":"27","author":"H Bryant","year":"2006","unstructured":"Bryant H, Robson PJ, Ullman R, Friedenreich C, Dawe U. Population-based cohort development in Alberta, Canada: a feasibility study. Chronic Dis Can. 2006;27:51\u20139.","journal-title":"Chronic Dis Can"},{"key":"5095_CR28","doi-asserted-by":"publisher","first-page":"E515","DOI":"10.9778\/cmajo.20160005","volume":"4","author":"PJ Robson","year":"2016","unstructured":"Robson PJ, Solbak NM, Haig TR, Whelan HK, Vena JE, Akawung AK, et al. Design, methods and demographics from phase I of Alberta\u2019s tomorrow project cohort: a prospective cohort profile. CMAJ Open. 2016;4:E515\u201327.","journal-title":"CMAJ Open"},{"key":"5095_CR29","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/j.1572-0241.2007.01217.x","volume":"102","author":"SE McGregor","year":"2007","unstructured":"McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol. 2007;102:1727\u201335.","journal-title":"Am J Gastroenterol"},{"key":"5095_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-230X-7-39","volume":"7","author":"MJ Sewitch","year":"2007","unstructured":"Sewitch MJ, Fournier C, Ciampi A, Dyachenko A. Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterol. 2007;7:39.","journal-title":"BMC Gastroenterol"},{"key":"5095_CR31","unstructured":"Canadian Partnership Against Cancer. Colorectal Cancer Screening in Canada: Program Performance Results Report, January 2009-December 2011. Toronto: Canadian Partnership Against Cancer; 2013."},{"key":"5095_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1572-0241.2004.30623.x","volume":"99","author":"L Rabeneck","year":"2004","unstructured":"Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004;99:1141\u20134.","journal-title":"Am J Gastroenterol"},{"key":"5095_CR33","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/ajg.2015.206","volume":"110","author":"KM Decker","year":"2015","unstructured":"Decker KM, Demers AA, Nugent Z, Biswanger N, Singh H. Longitudinal rates of colon cancer screening use in Winnipeg, Canada: the experience of a universal health-care system with an organized colon screening program. Am J Gastroenterol. 2015;110:1640\u20136.","journal-title":"Am J Gastroenterol"},{"key":"5095_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1471-2458-14-238","volume":"14","author":"A Duncan","year":"2014","unstructured":"Duncan A, Turnbull D, Wilson C, Osborne JM, Cole SR, Flight I, et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health. 2014;14:238.","journal-title":"BMC Public Health"},{"key":"5095_CR35","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1245\/s10434-009-0528-z","volume":"16","author":"LA Mack","year":"2009","unstructured":"Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Ann Surg Oncol. 2009;16:2092\u2013100.","journal-title":"Ann Surg Oncol"},{"key":"5095_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1155\/2009\/691850","volume":"23","author":"D Kottachchi","year":"2009","unstructured":"Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol. 2009;23:613\u20137.","journal-title":"Can J Gastroenterol"},{"key":"5095_CR37","volume-title":"2003 Canadian community health survey (CCHS) cycle 2.1","author":"Statistics Canada","year":"2003","unstructured":"Statistics Canada. 2003 Canadian community health survey (CCHS) cycle 2.1. 2003."},{"key":"5095_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3747\/co.v18i3.889","volume":"18","author":"HE Bryant","year":"2011","unstructured":"Bryant HE, Fekete SV, Major DH. Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact. Curr Oncol. 2011;18:111\u20138.","journal-title":"Curr Oncol"},{"key":"5095_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ypmed.2004.03.037","volume":"39","author":"SE McGregor","year":"2004","unstructured":"McGregor SE, Hilsden RJ, Murray A, Bryant HE. Colorectal cancer screening: practices and opinions of primary care physicians. Prev Med (Baltim). 2004;39:279\u201385.","journal-title":"Prev Med (Baltim)"},{"key":"5095_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7326\/M15-0983","volume":"164","author":"CD Jensen","year":"2016","unstructured":"Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164:456\u201363.","journal-title":"Ann Intern Med"},{"key":"5095_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12889-017-4634-8","volume":"18","author":"JM Osborne","year":"2017","unstructured":"Osborne JM, Wilson C, Duncan A, Cole SR, Flight I, Turnbull D, et al. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening? BMC Public Health. 2017;18:81.","journal-title":"BMC Public Health"},{"key":"5095_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1258\/jms.2008.008050","volume":"15","author":"MF Weber","year":"2008","unstructured":"Weber MF, Banks E, Ward R, Sitas F. Population characteristics related to colorectal cancer testing in new South Wales, Australia: results from the 45 and up study cohort. J Med Screen. 2008;15:137\u201342.","journal-title":"J Med Screen"},{"key":"5095_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1503\/cmaj.070558","volume":"177","author":"R Zarychanski","year":"2007","unstructured":"Zarychanski R, Chen Y, Bernstein CN, H\u00e9bert PC. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ. 2007;177:593\u20137.","journal-title":"CMAJ"},{"key":"5095_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/archinternmed.2011.212","volume":"171","author":"JS Goodwin","year":"2011","unstructured":"Goodwin JS, Singh A, Reddy N, Riall TS, Kuo Y-F. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171:1335\u201343.","journal-title":"Arch Intern Med"},{"key":"5095_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/1055-9965.EPI-13-0956","volume":"23","author":"L Rabeneck","year":"2014","unstructured":"Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, et al. Ontario\u2019s ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program. Cancer Epidemiol Biomark Prev. 2014;23:508\u201315.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5095_CR46","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nrg1919","volume":"7","author":"TA Manolio","year":"2006","unstructured":"Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812\u201320.","journal-title":"Nat Rev Genet"},{"key":"5095_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2458-9-421","volume":"9","author":"M Stommel","year":"2009","unstructured":"Stommel M, Schoenborn CA. Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006. BMC Public Health. 2009;9:421.","journal-title":"BMC Public Health"},{"key":"5095_CR48","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-07-2629","volume":"17","author":"GH Rauscher","year":"2008","unstructured":"Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748\u201357.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5095_CR49","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/bjc.2015.69","volume":"112","author":"RG Blanks","year":"2015","unstructured":"Blanks RG, Benson VS, Alison R, Brown A, Reeves GK, Beral V, et al. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women. Br J Cancer. 2015;112:1562\u20137.","journal-title":"Br J Cancer"},{"key":"5095_CR50","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/1471-2407-14-537","volume":"14","author":"GN Honein-AbouHaidar","year":"2014","unstructured":"Honein-AbouHaidar GN, Rabeneck L, Paszat LF, Sutradhar R, Tinmouth J, Baxter NN. Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario. BMC Cancer. 2014;14:537.","journal-title":"BMC Cancer"},{"key":"5095_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10900-007-9065-5","volume":"33","author":"PC Schroy","year":"2008","unstructured":"Schroy PC, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM. Has the surge in media attention increased public awareness about colorectal cancer and screening? J Community Health. 2008;33:1\u20139.","journal-title":"J Community Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T15:50:40Z","timestamp":1570636240000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5095"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5095-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"20 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics was granted by the Health Research Board of Alberta \u2013 Cancer Committee (Ethics ID: 25,985). Written consent was collected from each participant at enrollment into the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"177"}}